Please assess the completion status of the following clinical trial:

Trial Title: Catheter Ablation Versus Thoracoscopic Ablation to Patients With Permanent Atrial Fibrillation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Permanent atrial fibrillation documented on at least 2 ecg´s with more than 1 month between ecg´s. The diagnosis is verified on Holter.~* All patients have symptoms or do not tolerate rate control treatment.~Exclusion Criteria:~* Psychiatric disease or suspicion of incapability to give informed concent~* Females with birth giving potential~* Previous heart surgery~* Previous ablation for atrial fibrillation~* Life expectance less than 1 year~* Congenital heart disease~* Expected need for heart surgery~* Heart failure (NYHA class IV)~* Inability to be treated with anticoagulation~* In case of previous deep venous thromboembolism og stroke the investigators will individually consider if the patient is suitable for inclusion.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).